Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 84Other hematologic neoplasm 81Myeloid 14Genitourinary 6Sarcoma 5CNS 5Thoracic 3Head & Neck 3Classical hematology 3Plasma cell 2Other solid neoplasm 2Gynecologic 2Breast 2Other neoplasm 1Dermatologic 1

Conditions

Mesothelioma, Malignant 2Solitary Fibrous Tumor, Pleural 1Mesothelioma 1

Interventions

pembrolizumab 75Injections 67Carboplatin 38Pemetrexed 29Cisplatin 29Nivolumab 27Specimen Handling 24Interviews as Topic 24Cyclophosphamide 24atezolizumab 21tislelizumab 20Bevacizumab 20Paclitaxel 19Standard of Care 16Practice Guidelines as Topic 16fludarabine 15Docetaxel 15toripalimab 14Ipilimumab 14Educational Status 14Cetuximab 14Fluorouracil 13Oxaliplatin 12Etoposide 12olaparib 11durvalumab 11Methods 11Gemcitabine 11Early Intervention, Educational 11Drug Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Methotrexate × Other solid neoplasm × 1 year × Clear all
NCT02611037 2025-12-18

Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Completed
34 enrolled 12 charts
Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

NCT00354393 2025-07-15

Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma

The Cleveland Clinic

Phase 2 Completed
9 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

Data powered by HemOnc (CC BY 4.0) Colophon âš¡